Purchase Order SPE2DS25P1759
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,871.34 firm fixed-price purchase order to Fenwal, Inc. on July 30, 2025, for the supply of hand blood sealers. The contract, which carries an ultimate completion date of August 4, 2025, represents a routine procurement of specialized medical equipment without set-aside designation. Performance will occur at Fenwal's primary facility in Lake Zurich, Illinois. Fenwal, Inc., a global blood technology company and subsidiary...
- The Defense Logistics Agency, under its Medical Supply Chain program, awarded a $1,871.34 firm fixed-price purchase order to Fenwal, Inc. for a blood hand sealer on July 30, 2025. The contract, with an ultimate completion date of August 4, 2025, represents a routine procurement of specialized medical equipment supporting defense healthcare operations. No set-aside designation was applied to this award, indicating competitive procurement. Fenwal, Inc., a Lake Zurich, Illinois-based global blood...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical devices and supplies. The contract, valued at $1,871.34, is for the delivery of hand-operated blood pack sealers. This award supports critical healthcare programs, including military medical supply chains, biomedical research initiatives, and blood banking operations. Fenwal, Inc. is a registered vendor with the U.S. federal government and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- The Defense Logistics Agency Troop Support Medical has awarded Fenwal, Inc., a Fresenius Kabi company, a $1,062.50 firm-fixed-price purchase order for blood collection products and services. Fenwal, a global blood technology company, will provide items such as blood bags, tubing, solutions, and equipment to support the U.S. military's blood program and federal biomedical research. This contract was awarded without a set-aside designation due to Fenwal's specialized capabilities as a manufacturer...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables for the blood and biomedical research supply chain. The $1,148.65 contract is for the supply of blood collection assemblies and related products to support critical healthcare programs, including military medical supply chains and biomedical research initiatives. The contract has an ultimate...
- This is a $1,101.28 firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products based in Lake Zurich, Illinois. The contract is for the delivery of "BLOOD PACK WITH ANT" and has an ultimate completion date of January 30, 2025. Fenwal, Inc. is a global blood technology company and a key supplier to various federal agencies, providing critical medical supplies and equipment that support...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of blood pack units with anticoagulant, with a ceiling value of $1,101.28 and a completion date of June 30, 2025. Fenwal, Inc. is a global blood technology company and a registered vendor with the U.S. federal government, providing specialized medical equipment and consumables to support...
- This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...
The Defense Department's Medical Supply Chain division awarded a firm fixed-price purchase order valued at $1,871.34 to Fenwal, Inc. for the supply of a hand blood sealer. The contract, awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation, reflecting Fenwal's competitive capabilities in the federal marketplace. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform the work at its Illinois facility. Fenwal has established itself as a critical supplier to multiple federal agencies, including the Defense Logistics Agency and Defense Health Agency, providing specialized blood banking and transfusion products essential to military medical operations and healthcare initiatives. The hand blood sealer represents one component of Fenwal's broader portfolio of blood collection, separation, storage, and transfusion equipment that supports federal healthcare and biomedical missions. As a registered federal vendor since 2007, Fenwal continues to demonstrate its role in maintaining the Medical Supply Chain's operational readiness through the provision of specialized medical consumables and equipment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/8/25 |